Anemia management in chronic heart failure: Lessons learnt from chronic kidney disease

Kidney and Blood Pressure Research

Volumn 28, Issue 5-6, 2006, Pages 363-371

  Besarab, Anatole ^a   Soman, Sandeep ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Anemia; Epoetins; Heart failure; Kidney disease; Pathophysiology

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RISK FACTOR;

ANEMIA; CHRONIC DISEASE; ERYTHROPOIETIN; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS;

EID: 33644973853     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090191     Document Type: Article

References (38)

1. Al-Ahmad A, Rand WM, Manjunath G, et al: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-962.
2. Amann K, Breitbach M, Ritz E, Mall G: Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998;9:1018-1022.
3. Anand I, McMurray JJ, Whitmore J, et al: Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-154.
4. Androne AS, Katz S, Lamanca J, Hudaihed A, Hryniewicz K, Mancini D: Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-232.
5. Besarab A, Flaherty KK, Erslev A, et al: Clinical pharmacology and economics of recombinant human erythropoietin: The case for subcutaneous administration. J Am Soc Nephrol 1992;2:1405-1416.
6. Chatterjee B, Nydegger UE, Mohacsi P: Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists. Eur J Heart Fail 2000;2:393-398.
7. Crosato M, Steinborn W, Anker SD: Anemia in chronic congestive heart failure: frequency, prognosis, and treatment. Heart Failure Monitor 2003;4:2-6.
8. Delgado RM, Radovancevic R, Van Rossem CC, Gaemers SJM, Bracey A, Radovancevic B: Effect of administration of recombinant human erythropoietin in heart failure patients. Eur Heart J 2004;25(suppl 1):498.
9. Donnelly S: Why is erythropoietin made in the kidney? The kidney functions as a crit-meter. Am J Kidney Dis 2001;38:415-425.
10. Ezekowitz JA, Mc Alister FA, Amstrong RW: Anemia is common in heart failure and is associated with poor outcomes. Circulation 2003;107:223-231.
11. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-S119.
12. Gilbertson DT, Shuling L, Murray A, Herzog, C, Collins A: The competing risks of death vs. ESRD in Medicare beneficiaries 65+ with chronic kidney disease, CHF, and anemia. J Am Soc Nephrol 2002;13(suppl):abstr SA 848, p 439A.
13. Haber HL, Leavy JA, Kessler PD, et al: The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med 1991;324:353-358.
14. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786.
15. Hunt SA, Baker DW, Chin MH, et al: ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure), 2001.
16. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM: The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112-119.
17. Levin A, Thompson CR, Ethier J, et al: Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999;34:125-134.
18. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
19. Mancini DM, Katz SD, Lamanca J, Hudaihed A, Androne AS: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003;107:294-336.
20. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R: Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-1936.
21. McDonald K, et al: Effect of darvepoetin alfa on exercise tolerance in anemia patients with symptomatic chronic heart failure: a randomized, double-blind controlled trial. Oral presentation at the American College of Cardiology Meeting, ACC, 2005.
22. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM: Pathophysiology of anemia: focus on the heart and blood vessels. Nephrol Dial Transplant 2000;15(suppl 3):14-18.
23. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996;11:1277-1285.
24. Philipp S, Ollmann H, Schink T, et al: The impact of anemia and kidney function in congestive heart failure and preserved systolic function. Nephrol Dial Transplant 2005;20:915-919.
25. Rich MW, Beckham V, Wittenberg C, et al: A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
26. Rich MW, Shah AS, Vinson JM, et al: Iatrogenic congestive heart failure in older adults: clinical course and prognosis. J Am Geriatr Soc 1996;44:638-643.
27. Silverberg D: Outcomes of anemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant 2003;18(suppl 2):ii7-ii12.
28. Silverberg DS, Wexler D, Sheps D, et al: The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775-1780.
29. Silverberg DS, Wexler D, Blum M, et al: The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737-1744.
30. Silverberg DS, Wexler D, Blum M, et al: The effect of correction of anemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003;18:141-146.
31. Silverberg DS, Wexler D, Blum M, et al: Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. Isr Med Assoc 2003;5:337-339.
32. Silverberg DS, Wexler D, Blum M, et al: Effects of treatment with epoetin beta on outcomes in patients with anemia and chronic heart failure. Kidney Blood Press Res 2005;28:41-47.
33. Soman S, Besarab A, Ayyoub F, et al: The prevalence and morbidity of anemia and kidney disease in hospitalized patients with congestive heart failure (CHF). J Am Soc Nephrol 2005;19:abstr TH-PO973.
34. Szachniewicz J, Petruk-Kowalczyk J, Kaczmarek A, et al: Anemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003;90:303-308.
35. Tanner H, Moschovitis G, Kuster GM, et al: The prevalence of anemia in chronic heart failure. Int J Cardiol 2002;86:115-121.
36. US Renal Data System: USRDS 1999 Annual Data Report. IV. Patient characteristics at the start of ESRD: data from the HCFA medical evidence form. http://www.usrds.org/adr_1999.htm
37. US Renal Data System: USRDS 2002 Annual Data Report. II. Patients characteristics at the beginning of ESRD. http://www.usrds.org/atlas_2002.htm
38. Volpe M, Tritto C, Testa U, et al: Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol 1994;74:468-473.